The National Agency for Food and Drug Administration and Control (NAFDAC) has warned Nigerians against the sale, distribution, purchase and use of unregistered Menofix composition.
Menofix is sold as a hormone-free, vegetarian-friendly multivitamin and herbal supplement designed to help women navigate the physical and hormonal shifts of perimenopause and menopause.
In a public alert on X on Tuesday, NAFDAC said it received a complaint concerning the marketing and sale of Menofix capsules.
NAFDAC stated that the drug was unregistered and detrimental to health.
“Following investigation by the post marketing surveillance directorate, it was established that the complaint product, Menofix, is not registered with NAFDAC,” the agency said.
“Further review found that the product being marketed differs from similarly named products already registered by the agency.
“Two registered products with a similar name are Menofix herbal capsule (NAFDAC Reg. No. A7-103321L) and Menofix Powder (NAFDAC Reg. No. A7-103342L), both registered under the herbal and nutraceuticals category and manufactured by Gudugudu Herbal Worldwide Enterprises.”
NAFDAC said that the product is widely available for over-the-counter purchase, on online channels, and in open retail outlets.
The agency said that some ingredients in the circulating Menofix product have been associated with rare reports of liver-related adverse effects, such as hepatitis, elevated liver enzymes, jaundice, and liver failure.
According to the agency, monitoring is ongoing to get hold of the distribution line and resolve this issue.
“All NAFDAC zonal directors and state coordinators have been instructed to conduct surveillance and remove the unregistered product if found within their zones and states,” the agency stated.
“Retailers, healthcare professionals, and consumers are hereby advised to avoid the sale and use of unregistered products. All medical products must be purchased from authorized or licensed suppliers. The products’ authenticity and physical condition should be carefully checked.
“Healthcare professionals and consumers are advised to report any suspicion of the sale of substandard and falsified medicines or medical devices to the nearest NAFDAC office.”







